Abstract
Objective To investigate the clinical effects and safety of artificial liver support system (ALSS) in patients with jaundice hepatitis. Methods Seventy-two patients were treated with ALSS for 221 times, and 3.2 times on average. Compared the clinical manifestation, the main laboratory examination and the adverse reactions of the treatment. Fifty-six similar patients who were admitted to the hospital durtry the same time were as control. Results The patients undergoing artificial liver treatment showed significant improvements in clinical symptoms; TBIL, ALT, AST, NH3, TBA, and GGT reduced and PTA, ALB imcreased significantly. The incidence of adverse reaction was 16.7%, 88.89% of pationts in therapy group were cured or improved and 60.71% in the control group. The average duration of hospitalization:in (27.16±20.36) d treatment group, and (58.15±25.49)d normal control, there is a significant difference between the two groups. Conclusions ALSS can provide patients with comparatively secure and effective treatment for patients with jaundice hepatitis.
Key words
Jaundice hepatitis /
Curative effect
Cite this article
Download Citations
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
PDF(2371 KB)
